Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Singulair (montelukast) comes up frequently during cold season because it’s designed to prevent the respiratory symptoms that winter and cold air trigger in many people. When cold air hits your airways, your body releases inflammatory chemicals called leukotrienes that can cause tightening, congestion, and asthma attacks—and Singulair specifically blocks those chemicals before they cause problems.
For someone who experiences seasonal asthma flare-ups or allergy symptoms every November through March, a daily preventive medication that addresses the root mechanism can feel like a game-changer. However, what makes Singulair particularly important to understand—especially for families managing brain health and cognitive care—is that the FDA issued a significant safety warning in 2020 requiring a Boxed Warning about serious mental health side effects. These include mood changes, depression, suicidal thoughts, and anxiety that can affect patients of all ages, which makes the decision to use this medication more nuanced than simply addressing respiratory symptoms alone.
Table of Contents
- How Cold Air and Allergies Trigger the Need for Singulair
- The FDA’s Mental Health Warning—What You Need to Know Before Starting
- When Singulair Actually Works—And When It Doesn’t
- Using Singulair Safely During Cold Months—Practical Considerations
- What Singulair Cannot Do—Critical Limitations
- Singulair Use Across Different Ages—What Changes
- Moving Forward—Evaluating Whether Singulair Is Right for Your Cold Season
- Conclusion
How Cold Air and Allergies Trigger the Need for Singulair
Cold winter air and indoor allergens create a perfect storm for respiratory inflammation. When you breathe in cold, dry air, your airways respond by releasing leukotrienes—inflammatory molecules that cause the smooth muscles in your airways to tighten and mucus production to increase. The same chemical cascade happens when you encounter dust mites, pet dander, or seasonal mold spores that concentrate indoors during winter months. This is why people with asthma or allergic rhinitis often notice their symptoms worsen dramatically between November and March, even if they’ve been stable the rest of the year.
Singulair works by blocking these leukotrienes at the source, preventing the inflammatory cascade before it starts. Unlike a rescue inhaler that opens your airways after they’ve already tightened, Singulair is purely preventive—it stops the problem before symptoms develop. For someone managing both dementia care responsibilities and their own respiratory health, this preventive approach can reduce the unpredictability of sudden breathing difficulties or congestion that interferes with daily functioning. The clinical data shows that Singulair is most effective for people whose asthma or allergies are triggered specifically by allergens or exercise in cold weather, rather than those with year-round asthma that’s driven by other factors. If your respiratory symptoms are seasonal and correlate with cold months, you’re more likely to see meaningful benefit than someone whose airways are irritable due to chronic airway disease.
The FDA’s Mental Health Warning—What You Need to Know Before Starting
In 2020, the FDA required a Boxed Warning on Singulair (the strongest type of safety warning) because post-market surveillance and clinical observations revealed that some patients experienced serious psychiatric effects including depression, mood swings, anxiety, and in some cases, suicidal thinking. This warning applies to patients of all ages—children, adolescents, and adults—and the mental health effects can occur at any point during treatment, not just when starting the medication. For caregivers and families managing cognitive health, this warning deserves particular attention. If you or a family member has a history of depression, anxiety, bipolar disorder, or other psychiatric conditions, the decision to use Singulair requires weighing the respiratory benefit against the potential psychiatric risk.
The warning doesn’t mean everyone will experience these side effects—many people tolerate the medication without problems—but it does mean that mood changes should be monitored closely, and any new or worsening depression, anxiety, or behavioral changes warrant immediate communication with your healthcare provider. The mental health risk is not theoretical or rare enough to dismiss. The FDA took the step of adding a Boxed Warning because the signal was strong enough to warrant the most serious level of caution. This is particularly important information if you’re considering Singulair for a family member or if you have your own history of mental health concerns, as the respiratory benefit may not outweigh the psychiatric risk in some cases.
When Singulair Actually Works—And When It Doesn’t
Singulair’s effectiveness depends significantly on what’s driving your respiratory symptoms. It works best for people whose asthma or allergies are triggered by allergens (like dust mites and pollen) or by exercise in cold weather. If you have exercise-induced asthma that flares up when you go for a winter run, or if your allergies are driven by the dust and pet dander concentrated in your home during winter, Singulair can be quite effective at preventing those episodes. However, effectiveness varies considerably from person to person, and Singulair doesn’t work well for everyone. Some people see dramatic improvement in their symptoms within the first week or two of starting the medication, while others notice minimal change after several weeks of consistent use.
If your asthma is driven by viral infections (which become more common in winter), by occupational exposures, or by intrinsic airway hyperresponsiveness rather than allergens, Singulair may not provide the relief you’re hoping for. Your doctor should evaluate your specific trigger patterns before recommending Singulair, as prescribing it without understanding whether your symptoms fit the drug’s mechanism can lead to months of disappointment and wasted medication costs. A practical example: Sarah has seasonal allergies and mild asthma that flares only from October through February, triggered by the heating systems and indoor dust in her home. For Sarah, Singulair works well—she takes it daily through the winter, her symptoms diminish, and she stops it in spring. But her neighbor Michael has year-round asthma triggered by viral respiratory infections and environmental irritants; for him, Singulair provides minimal benefit because his problem isn’t leukotriene-driven seasonal inflammation but rather chronic airway sensitivity. Without proper diagnosis of trigger patterns, Michael might spend three months taking Singulair with no improvement.
Using Singulair Safely During Cold Months—Practical Considerations
If you and your healthcare provider have determined that Singulair is appropriate for your cold-season respiratory needs, using it safely requires a few key practices. Take the medication consistently every day, not just when you’re having symptoms, because Singulair works as a preventive—missing doses undermines its effectiveness. Most people take it in the evening, which can actually help with timing since respiratory symptoms often worsen at night when you’re lying down and mucus accumulates in your airways. Monitor your mood and mental health closely while taking Singulair, especially in the first few weeks. Keep a simple log of any mood changes, new anxiety, sleep problems, or behavioral shifts you notice.
If someone else is taking Singulair (particularly a child), caregivers should watch for personality changes, increased irritability, or withdrawn behavior. This isn’t meant to create anxiety—it’s simply being informed about a known risk so you can catch problems early and discuss them with your doctor immediately if they occur. Compare your respiratory improvement against this mental health monitoring. If you’re sleeping better and breathing more easily but noticing concerning mood changes, that’s a trade-off worth discussing with your doctor. You might explore timing adjustments, dose modifications, or alternative preventive approaches like nasal corticosteroids or antihistamines, which address seasonal symptoms through different mechanisms and don’t carry the same psychiatric warning. Your doctor can help you weigh whether the respiratory benefit justifies continuing the medication or whether a different approach better fits your overall health profile.
What Singulair Cannot Do—Critical Limitations
This is perhaps the most important limitation to understand: Singulair is purely preventive and cannot treat an acute asthma attack or respiratory crisis. If you’re having sudden shortness of breath, chest tightness, or acute wheezing, taking a Singulair tablet will not help—you need a rescue inhaler (like albuterol) or emergency medical care. Some people mistakenly believe that because Singulair helps prevent asthma symptoms, it can also relieve them once they occur, but this is a dangerous misunderstanding.
Singulair takes hours to work at its best, and it doesn’t have the immediate bronchodilating effect needed in an emergency. Never rely on Singulair alone as your asthma management strategy, especially if you have moderate to severe asthma. You still need a rescue inhaler available at all times, and if you’re experiencing frequent asthma attacks despite taking Singulair daily, your overall asthma management plan needs adjustment—whether that means adding other controller medications, identifying new triggers, or considering that Singulair simply isn’t the right choice for your specific situation. Cold season shouldn’t mean white-knuckling through breathing difficulties while waiting for a daily preventive to work; if symptoms persist despite consistent Singulair use, escalation of care is appropriate.
Singulair Use Across Different Ages—What Changes
Singulair is FDA-approved for children as young as one year old (for asthma) and children as young as two years old (for allergic rhinitis), which means it’s been extensively studied in pediatric populations. For caregivers managing a young child’s winter asthma or an aging parent’s seasonal allergies, understanding the age-appropriate considerations helps inform your discussions with their healthcare providers. A three-year-old with exercise-induced asthma triggered by cold-weather play can safely take Singulair, as can an 82-year-old with seasonal allergic rhinitis—the medication itself doesn’t have age restrictions.
However, the mental health warning requires extra vigilance in children and adolescents, whose developing brains may be more vulnerable to mood effects, and in older adults, who may already be taking medications that interact with Singulair or managing depression or anxiety. For example, an older adult on antidepressants needs to be monitored especially carefully for any additive mood effects, and a teenager with a history of anxiety might need more frequent check-ins while taking Singulair. Your healthcare provider should discuss these age-related considerations and adjust monitoring frequency accordingly.
Moving Forward—Evaluating Whether Singulair Is Right for Your Cold Season
The decision to use Singulair should flow from a clear understanding of what’s driving your respiratory symptoms and a careful weighing of the respiratory benefit against the mental health risks. Start by working with your healthcare provider to identify your specific triggers: Is your winter asthma driven by cold air, indoor allergens, exercise, or something else? Are your symptoms mild enough that they can be managed with other approaches, or are they significantly impacting your daily life? Does your personal or family history of psychiatric conditions suggest that the FDA’s mental health warning is a particular concern for you? If Singulair seems like a reasonable fit, discuss a trial period—typically four to six weeks—where you take the medication consistently while monitoring respiratory symptoms and mood. If respiratory improvement is significant and no concerning mental health effects emerge, continuing through the cold season makes sense.
If mental health changes become apparent or respiratory improvement is minimal, discontinuing or trying a different approach is equally valid. Respiratory health matters, but so does emotional and mental wellbeing, and there are multiple options for cold-season symptom management. Your healthcare provider can help you navigate these options and find the approach that best protects your overall health.
Conclusion
Singulair comes up repeatedly during cold season because it addresses the specific mechanism that makes winter respiratory symptoms so common: cold air and indoor allergen exposure trigger inflammatory chemicals in your airways, and Singulair blocks those chemicals before they cause tightening and congestion. For people whose asthma or allergies fit this pattern—those whose symptoms are seasonal, allergen-triggered, or worsened by exercise in cold weather—the medication can provide meaningful relief during the months when respiratory symptoms would otherwise be frequent and unpredictable. The critical aspect of modern Singulair use is understanding the FDA’s 2020 mental health warning and taking it seriously as you decide whether the medication is right for you.
Weigh the respiratory benefit against the documented psychiatric risks, monitor mood and mental health closely if you do take it, and maintain open communication with your healthcare provider about whether the medication is delivering enough benefit to justify continuing it. Cold season doesn’t have to mean struggling with breathing difficulties, but it also shouldn’t mean risking mood changes or other psychiatric effects. Work with your healthcare team to find the approach that protects your entire health picture, not just your respiratory system.
